How UC Is Expanding Access to Menopause Care

Value of the Information & Strength of the Argument

The presentation provides valuable insights into the systemic gaps in menopause care and offers a concrete, multi-pronged solution. The argumentation is well-structured, moving from problem identification (prevalence, undertreatment, historical context) to proposed solutions (training, infrastructure, care models). The speakers support their claims with references to specific studies (Mayo Clinic economic burden, WHI, JAMA 2024) and institutional data (UCLA’s 55% increase in visits). The MAPS system is presented as a practical tool that reduces cognitive load and standardizes care, with evidence of its effectiveness at UCLA. However, some claims rely on unpublished data (Epic research) and the presentation is largely descriptive, lacking rigorous comparative analysis or independent validation.

Scientific Rigor, Source Quality, Title Accuracy

The speakers are credible experts in the field, and they reference several key studies and articles, including the 2023 Mayo Clinic economic analysis, the 2002 WHI trial, and a 2024 JAMA clinical review. They also mention the FDA’s removal of the black box warning in 2025. The description provides links to UCTV’s health and women’s health channels, which serve as general references. The title accurately reflects the content, focusing on the UC Menopause Collaborative’s mission. The presentation is a mix of expert opinion and programmatic description, with some data from internal sources. The sources cited are relevant and generally reliable, though not all are formally published.

The title accurately reflects the content, which focuses on the UC Menopause Collaborative's efforts to expand access to menopause care across University of California health centers.

8/10

The presentation is given by two board-certified OB/GYN specialists who direct menopause programs at UC San Diego and UCLA. They reference specific studies (Mayo Clinic 2023, WHI, JAMA 2024 clinical review) and describe institutional data and a structured clinical tool (MAPS). However, the talk is largely descriptive and programmatic, with limited peer-reviewed citations and some unpublished data (Epic research, internal UCLA metrics).

• 00:00Why Menopause Care Needs a UC Collaborative
• 00:50Why Midlife Symptoms Need Better Care
• 03:20How Hot Flashes Affect Health Beyond Discomfort
• 05:25Why Hormone Therapy Prescribing Changed
• 11:32How Frontline Clinicians Can Close Care Gaps
• 16:58How MAPS Supports Menopause Visits
• 19:03UCLA Program Growth and UC-Wide Priorities
• 25:21Questions on Equity, Research, and Treatment Options

• UCTV - Health & Medicine — General health and medicine content from UCTV, including this presentation.
• UCTV - UC San Diego Women's Health Symposium — Series page for the symposium where this talk was recorded.
• UCTV - Motherhood Channel — Related content on women's health topics.
• UCTV - Main Channel — General UCTV platform.

• Mayo Clinic Proceedings (2023) - Economic burden of menopause — Referenced in the talk for the $26 billion annual economic burden of menopause symptoms.
• JAMA (2024) - Clinical review of WHI — Referenced as a recent review clarifying the WHI findings and supporting hormone therapy for symptomatic younger women.

• www.youtube.com